Last updated on February 2018

DNS-3379 vs. Placebo in Stroke Rehabilitation

Brief description of study

This is a randomized, double-blind, placebo-controlled parallel group outpatient 42-day treatment study that will utilize standard stroke rehabilitation outcome measures to evaluate the effect of DNS-3379 on upper extremity motor recovery in subjects following ischemic stroke.

Clinical Study Identifier: NCT03254160

Contact Investigators or Research Sites near you

Start Over

Royal Adelaide Hospital

Adelaide, Australia
  Connect »

Repatriation General Hospital

Daw Park, Australia
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.